ES2060606T3 - Utilizacion de derivados de oxazolidinonas 5-(fenil-sustituido) para el tratamiento de depresiones. - Google Patents

Utilizacion de derivados de oxazolidinonas 5-(fenil-sustituido) para el tratamiento de depresiones.

Info

Publication number
ES2060606T3
ES2060606T3 ES87730149T ES87730149T ES2060606T3 ES 2060606 T3 ES2060606 T3 ES 2060606T3 ES 87730149 T ES87730149 T ES 87730149T ES 87730149 T ES87730149 T ES 87730149T ES 2060606 T3 ES2060606 T3 ES 2060606T3
Authority
ES
Spain
Prior art keywords
treatment
substituted
fenyl
depressions
oxazolidinone derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87730149T
Other languages
English (en)
Inventor
Helmut Dr Wachtel
Herbert H Dr Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2060606T3 publication Critical patent/ES2060606T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

APLICACION DE 5-(FENIL-SUST)-OXAZOLIDINONAS AL TRATAMIENTO DE DEPRESIONES.
ES87730149T 1986-11-14 1987-11-13 Utilizacion de derivados de oxazolidinonas 5-(fenil-sustituido) para el tratamiento de depresiones. Expired - Lifetime ES2060606T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863639225 DE3639225A1 (de) 1986-11-14 1986-11-14 Verwendung von 5-(subst. phenyl)-oxazolidinonderiaten als psychopharmaka

Publications (1)

Publication Number Publication Date
ES2060606T3 true ES2060606T3 (es) 1994-12-01

Family

ID=6314130

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87730149T Expired - Lifetime ES2060606T3 (es) 1986-11-14 1987-11-13 Utilizacion de derivados de oxazolidinonas 5-(fenil-sustituido) para el tratamiento de depresiones.

Country Status (9)

Country Link
US (1) US4824838A (es)
EP (1) EP0270482B1 (es)
JP (1) JPS63183530A (es)
AT (1) ATE96317T1 (es)
AU (1) AU593694B2 (es)
CA (1) CA1306197C (es)
DE (2) DE3639225A1 (es)
DK (1) DK591787A (es)
ES (1) ES2060606T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783591A (en) * 1984-10-19 1998-07-21 Schering Aktiengesellschaft Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
US5066662A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors
US5066665A (en) * 1990-05-21 1991-11-19 Warner-Lambert Co. Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors
MX9706086A (es) * 1995-02-10 1997-10-31 Schering Ag Preparaciones farmaceuticas para inhibicion de tnf.
DE19540475A1 (de) * 1995-10-20 1997-04-24 Schering Ag Chirale Methylphenyloxazolidinone
FR2753449B1 (fr) * 1996-09-13 1998-12-04 Union Pharma Scient Appl Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2655369A1 (de) * 1976-12-03 1978-06-08 Schering Ag 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung
DE3438839A1 (de) * 1984-10-19 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische praeparate

Also Published As

Publication number Publication date
EP0270482A3 (en) 1990-05-02
JPS63183530A (ja) 1988-07-28
DK591787D0 (da) 1987-11-11
US4824838A (en) 1989-04-25
DE3787954D1 (de) 1993-12-02
DK591787A (da) 1988-05-15
AU8114387A (en) 1988-05-19
ATE96317T1 (de) 1993-11-15
EP0270482A2 (de) 1988-06-08
DE3639225A1 (de) 1988-05-19
CA1306197C (en) 1992-08-11
EP0270482B1 (de) 1993-10-27
AU593694B2 (en) 1990-02-15

Similar Documents

Publication Publication Date Title
ATE269290T1 (de) Benzoylderivate
FI873363A0 (fi) Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet.
NO910187D0 (no) Fremgangsmaate for fremstilling av indolsubstituerte, heteroaromatiske femringforbindelser.
ES505721A0 (es) Procedimiento de obtencion de una composicion a base de derivados de urea para el tratamiento de textiles.
DK249389D0 (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
ES2053748T3 (es) Oxazoles y tiazoles para el tratamiento de la demencia senil.
ES493812A0 (es) Procedimiento para el tratamiento de azufre insoluble.
DK336688D0 (da) Nucleosider od fremgangsmaade til fremstilling deraf
DK0810220T3 (da) Arylacrylamidderivater som 5-HT1-agonister eller -antagonister
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
MX9205549A (es) Metodo para el tratamiento de vih.
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
ES2060606T3 (es) Utilizacion de derivados de oxazolidinonas 5-(fenil-sustituido) para el tratamiento de depresiones.
SE8003228L (sv) Nya derivat av 5h-furanon-2 och 3h-dihydrofuranon-2, deras framstellningssett och terapeutiska anvendning
SE7705310L (sv) Kinazolinderivat
ES2018208B3 (es) Derivados de hidroxipirazol, procedimiento para su obtencion y su aplicacion contra microorganismos.
DE68901994D1 (de) Propanaminderivate.
ES2022896B3 (es) Derivados de azol utiles para el control de enfermedades vegetales.
ES241316Y (es) Dispositivo ensanchador para el tratamiento de displasais dela cadera.
DK149590C (da) Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser
DK207086D0 (da) Anvendelse af dopaminagonister
DK585984D0 (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
ES2032797T3 (es) Agente terapeutico para el tratamiento de la enfermedad ulcera peptica.
SE7713587L (sv) Forfarande for framstellning av oxazolidindionderivat av vinkaalkaloider
ES512448A0 (es) Procedimiento para el tratamiento de una escoria fosfurada.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 270482

Country of ref document: ES